What is the recommended dosing for Tamiflu (oseltamivir) in pediatric patients with influenza, considering weight and potential renal impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Dosing for Tamiflu (Oseltamivir)

For children ≥1 year, use weight-based dosing: 30 mg twice daily for ≤15 kg, 45 mg twice daily for >15-23 kg, 60 mg twice daily for >23-40 kg, and 75 mg twice daily for >40 kg, administered for 5 days when treating influenza. 1, 2

Weight-Based Dosing Algorithm for Children ≥1 Year

Treatment dosing (5 days):

  • ≤15 kg (≤33 lb): 30 mg twice daily = 5 mL oral suspension 1, 2
  • >15-23 kg (>33-51 lb): 45 mg twice daily = 7.5 mL oral suspension 1, 3, 2
  • >23-40 kg (>51-88 lb): 60 mg twice daily = 10 mL oral suspension 1, 3, 2
  • >40 kg (>88 lb): 75 mg twice daily = 12.5 mL oral suspension 1, 4, 2

Prophylaxis dosing (10 days): Use the same weight-based doses but give once daily instead of twice daily 1, 4, 2

Infant Dosing (<1 Year)

Critical distinction: Term vs preterm infants must be made before dosing. 1

Term Infants (≥37 weeks gestation at birth):

  • 0-8 months: 3 mg/kg per dose twice daily = 0.5 mL/kg oral suspension 1, 4, 2
  • 9-11 months: 3.5 mg/kg per dose twice daily 1, 4
  • Treatment duration: 5 days 1
  • Prophylaxis (3-8 months only): 3 mg/kg once daily for 10 days 1

Preterm Infants (based on postmenstrual age = gestational age + chronological age):

  • <38 weeks PMA: 1.0 mg/kg twice daily 1
  • 38-40 weeks PMA: 1.5 mg/kg twice daily 1
  • >40 weeks PMA: 3.0 mg/kg twice daily 1

Never use the 3 mg/kg term infant dose for preterm infants—this causes toxic drug accumulation due to immature renal function. 1, 4

Renal Impairment Adjustments

For creatinine clearance 10-30 mL/min: Reduce to once daily dosing instead of twice daily 1, 4

  • Give the child's weight-based dose once daily for 5 days (treatment) 1
  • For prophylaxis: give half the standard once-daily dose daily, OR give the full once-daily dose every other day for 10 days (5 total doses) 1

No dose adjustment needed for CrCl ≥30 mL/min 1, 3

Administration Considerations

Give oseltamivir with food to reduce gastrointestinal side effects (nausea/vomiting occur in ~10% of patients). 1, 4, 3

Oral suspension concentration: 6 mg/mL when reconstituted by pharmacist 1, 2

Initiate treatment within 48 hours of symptom onset for maximum benefit—this reduces illness duration by 1-1.5 days. 4, 5

Critical Pitfalls to Avoid

  • Never use the fixed unit doses (30,45,60,75 mg) intended for children ≥1 year in infants <1 year—these doses are too high 1
  • Never confuse GFR with creatinine clearance when adjusting for renal impairment 1
  • Never use term infant dosing for preterm infants without calculating postmenstrual age first 1, 4
  • Never confuse treatment dosing (twice daily) with prophylaxis dosing (once daily) 4

Adolescents and Adults (≥13 Years)

Standard dose: 75 mg twice daily for 5 days (treatment) or 75 mg once daily for 10 days (prophylaxis) 1, 4, 2

References

Guideline

Oseltamivir Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Oseltamivir Dosing Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Oseltamivir Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.